Immune Pharmacytes: Nanoparticle-Modified Leukocytes for Immunotherapy
Invention type: Technology
/
Case number: #13509H
The invention provides compositions and methods for delivering agents to localized regions, tissues, or organs in vivo by conjugating agent-loaded nanoparticles to cells having homing capability. The agents may be therapeutic or diagnostic agents such as cancer chemotherapeutic agents and imaging agents respectively.
Researchers
Matthias Stephan
/
Jae Hyun (James) Moon
/
Anna Bershteyn
/
Darrell J Irvine
Departments: David H Koch Institute for Integrative Cancer Res
Technology Areas: Diagnostics: Imaging Agents / Drug Delivery: Microparticles & Nanoparticles / Therapeutics: Small Molecules
Impact Areas: Healthy Living
-
methods and compositions for localized agent delivery
United States of America | Granted | 9,283,184 -
methods and compositions for localized nanoparticle delivery to a tumor
European Patent Convention | Granted | 2,398,466 -
methods and compositions for localized agent delivery
United States of America | Granted | 9,393,199 -
methods and compositions for localized nanoparticle delivery to a tumor
France | Granted | 2,398,466 -
methods and compositions for localized nanoparticle delivery to a tumor
Germany | Granted | 2,398,466 -
methods and compositions for localized nanoparticle delivery to a tumor
Ireland | Granted | 2,398,466 -
methods and compositions for localized nanoparticle delivery to a tumor
Italy | Granted | 2,398,466 -
methods and compositions for localized nanoparticle delivery to a tumor
Spain | Granted | 2,398,466 -
methods and compositions for localized nanoparticle delivery to a tumor
Switzerland | Granted | 2,398,466 -
methods and compositions for localized nanoparticle delivery to a tumor
United Kingdom | Granted | 2,398,466
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.